Newsfeeds Archive - Spark Newswire

1 minute read

Anixa Biosciences Announces Japanese Patent On Ovarian Cancer Vaccine Technology

January 23, 9:06 AM

Broad coverage extended to Japan and related regionsSAN JOSE, Calif., Jan. 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a clinical-stage

ANIX

2 minute read

Anixa Biosciences Reveals Updated Data From Breast Cancer Vaccine Trial, Says ‘Exceeded Expectations’

By Vandana Singh

December 7, 10:58 AM

Anixa Biosciences Inc (NASDAQ: ANIX) announced new and updated results from the Phase 1 trial of its breast cancer vaccine.

ANIX

1 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

December 7, 9:07 AM

Gainers Dare Bioscience (NASDAQ:DARE) shares rose 31.1% to $0.46 during Thursday’s pre-market session. The company’s market cap stands…

ANIX

2 minute read

Anixa Biosciences To Host Conference Call This Evening To Discuss New Data From Ongoing Phase 1 Study Of Breast Cancer Vaccine

By Benzinga Newsdesk

December 6, 5:19 PM

– Data to be released at approximately 6:00 p.m. ET, following presentation at 2023 SABCS –– Conference call to commence at 6:30 p.m. ET –SAN JOSE, Calif., Dec. 6, 2023 /PRNewswire/ -- Anixa Biosciences,

ANIX

1 minute read

Anixa Biosciences Announces European Patent On Ovarian Cancer Vaccine Technology

By Benzinga Newsdesk

November 27, 9:44 AM

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has received an

ANIX

2 minute read

Anixa Biosciences Completes Treatment Of First Patient Cohort In Ovarian Cancer CAR-T Clinical Trial

By Benzinga Newsdesk

October 13, 8:35 AM

- With no dose-limiting toxicities observed, treatment of second dose cohort to beginSAN JOSE, Calif., Oct. 13, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology

ANIX

37 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

October 3, 2:37 PM

On Tuesday, 647 companies set new 52-week lows.

AADI

1 minute read

Anixa Biosciences Announces Issuance Of Additional U.S. Patent For Ovarian Cancer Vaccine Technology

By Benzinga Newsdesk

October 3, 8:34 AM

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the U.S. Patent and Trademark Office (USPTO) has

ANIX

1 minute read

Anixa Biosciences Announces Invited Presentation On Ovarian Cancer CAR-T Therapy At The 8th Annual CAR-TCR Summit

By Happy Mohamed

August 14, 8:58 AM

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Dr. Pamela D. Garzone,

ANIX

1 minute read

Anixa Biosciences Announces Notice Of Allowance Of Additional Patent On Ovarian Cancer Vaccine Technology

By Happy Mohamed

July 27, 8:37 AM

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ:ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the U.S. Patent and

ANIX